ArticleCureus2026
The Initiation of Laparoscopic Gastric Surgery in an Academic Hospital in Greece: Early Results.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Recent studies have demonstrated that minimally invasive techniques are a viable alternative to open surgery for the treatment of gastric cancer (GC), providing both intraoperative and postoperative benefits for patients. In addition, preliminary data suggest that laparoscopic gastrectomy (LG) may have morbidity, mortality, and oncologic outcomes comparable to those of the traditional open approach for treating GC. This study aimed to review our institution's experience with totally laparoscopic gastrectomy for the treatment of early- and advanced-stage GC. Methods A retrospective study was conducted to examine the short-term outcomes of LG performed at Attikon University Hospital in Athens between June 2022 and November 2024. We reviewed postoperative complications, surgical margins, the number of resected lymph nodes, estimated blood loss, length of hospital stay, and recurrence rates. Results Fourteen patients with gastric adenocarcinoma were included in the study. The mean operative time was four hours, and blood loss was minimal. The median length of hospital stay was six days. The mean number of harvested lymph nodes was 16. Early postoperative complications occurred in two patients and included delayed gastric emptying and pulmonary infection. There were no postoperative deaths. Conclusions Totally laparoscopic gastrectomy represents a feasible treatment option for gastric malignancy. Our early institutional experience demonstrates the technical feasibility of this approach, with favorable perioperative outcomes and encouraging short-term survival. While the benefits of the laparoscopic approach are well recognized, larger prospective studies with long-term follow-up are required to confirm its oncologic equivalence or superiority over open gastrectomy (OG) in patients with advanced disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.